Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.

The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.

McConeghy KW, Bleasdale SC, Rodvold KA.

Clin Infect Dis. 2013 Dec;57(12):1760-5. doi: 10.1093/cid/cit560. Epub 2013 Aug 28. Review.

PMID:
23985343
3.

Common use of the empirical combination of vancomycin and a β-lactam for staphylococcal bacteremia.

Cleveland KO, Mazumder SA, Gelfand MS.

Clin Infect Dis. 2014 Apr;58(7):1041-2. doi: 10.1093/cid/ciu029. Epub 2014 Jan 14. No abstract available.

PMID:
24429429
4.

Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.

Wong D, Wong T, Romney M, Leung V.

Ann Clin Microbiol Antimicrob. 2016 Apr 26;15:27. doi: 10.1186/s12941-016-0143-3.

5.

CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.

Tong SY, Nelson J, Paterson DL, Fowler VG Jr, Howden BP, Cheng AC, Chatfield M, Lipman J, Van Hal S, O'Sullivan M, Robinson JO, Yahav D, Lye D, Davis JS; CAMERA2 study group and the Australasian Society for Infectious Diseases Clinical Research Network.

Trials. 2016 Mar 31;17:170. doi: 10.1186/s13063-016-1295-3.

6.

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.

Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Cosgrove SE, Sakoulas G, Perencevich EN.

BMC Infect Dis. 2011 Oct 19;11:279. doi: 10.1186/1471-2334-11-279.

7.

Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Kim SH, Kim KH, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW.

Antimicrob Agents Chemother. 2008 Jan;52(1):192-7. Epub 2007 Nov 5.

8.

Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.

McDanel JS, Perencevich EN, Diekema DJ, Herwaldt LA, Smith TC, Chrischilles EA, Dawson JD, Jiang L, Goto M, Schweizer ML.

Clin Infect Dis. 2015 Aug 1;61(3):361-7. doi: 10.1093/cid/civ308. Epub 2015 Apr 21.

PMID:
25900170
9.

The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.

Blumenthal KG, Shenoy ES, Huang M, Kuhlen JL, Ware WA, Parker RA, Walensky RP.

PLoS One. 2016 Jul 20;11(7):e0159406. doi: 10.1371/journal.pone.0159406. eCollection 2016.

10.

Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial.

Davis JS, Sud A, O'Sullivan MVN, Robinson JO, Ferguson PE, Foo H, van Hal SJ, Ralph AP, Howden BP, Binks PM, Kirby A, Tong SYC; Combination Antibiotics for MEthicillin Resistant Staphylococcus aureus (CAMERA) study group; Combination Antibiotics for MEthicillin Resistant Staphylococcus aureus (CAMERA) study group, Tong S, Davis J, Binks P, Majumdar S, Ralph A, Baird R, Gordon C, Jeremiah C, Leung G, Brischetto A, Crowe A, Dakh F, Whykes K, Kirkwood M, Sud A, Menon M, Somerville L, Subedi S, Owen S, O'Sullivan M, Liu E, Zhou F, Robinson O, Coombs G, Ferguson P, Ralph A, Liu E, Pollet S, Van Hal S, Foo H, Van Hal S, Davis R.

Clin Infect Dis. 2016 Jan 15;62(2):173-180. doi: 10.1093/cid/civ808. Epub 2015 Sep 8.

PMID:
26349552
11.

Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Stryjewski ME, Szczech LA, Benjamin DK Jr, Inrig JK, Kanafani ZA, Engemann JJ, Chu VH, Joyce MJ, Reller LB, Corey GR, Fowler VG Jr.

Clin Infect Dis. 2007 Jan 15;44(2):190-6. Epub 2006 Dec 8.

PMID:
17173215
12.

Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.

Khatib R, Saeed S, Sharma M, Riederer K, Fakih MG, Johnson LB.

Eur J Clin Microbiol Infect Dis. 2006 Mar;25(3):181-5.

PMID:
16505987
14.

Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection.

Takata T, Miyazaki M, Futo M, Hara S, Shiotsuka S, Kamimura H, Yoshimura H, Matsunaga A, Nishida T, Ishikura H, Ishikawa T, Tamura K, Tsuji BT.

Scand J Infect Dis. 2013 Mar;45(3):203-12. doi: 10.3109/00365548.2012.723221. Epub 2012 Oct 31.

PMID:
23113753
15.

Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?

Paul M, Zemer-Wassercug N, Talker O, Lishtzinsky Y, Lev B, Samra Z, Leibovici L, Bishara J.

Clin Microbiol Infect. 2011 Oct;17(10):1581-6. doi: 10.1111/j.1469-0691.2010.03425.x. Epub 2010 Dec 14.

16.

Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia.

Dhand A, Sakoulas G.

Clin Ther. 2014 Oct 1;36(10):1303-16. doi: 10.1016/j.clinthera.2014.09.005. Epub 2014 Oct 23. Review.

PMID:
25444563
18.

Using MRSA Screening Tests To Predict Methicillin Resistance in Staphylococcus aureus Bacteremia.

Butler-Laporte G, Cheng MP, Cheng AP, McDonald EG, Lee TC.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7444-7448. Print 2016 Dec.

19.

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.

Chang FY, Peacock JE Jr, Musher DM, Triplett P, MacDonald BB, Mylotte JM, O'Donnell A, Wagener MM, Yu VL.

Medicine (Baltimore). 2003 Sep;82(5):333-9.

20.

Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia.

Seah J, Lye DC, Ng TM, Krishnan P, Choudhury S, Teng CB.

Virulence. 2013 Nov 15;4(8):734-9. doi: 10.4161/viru.26909. Epub 2013 Oct 28. No abstract available.

Supplemental Content

Support Center